Multi-epitope TARP peptide autologous dendritic cell vaccination

TARP peptide autologous dendritic cell vaccine · National Cancer Institute (NCI)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Multi-epitope TARP peptide autologous dendritic cell vaccination, covering 2022-03-08 to 2022-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer [Phase 2]

See pricing